Contract 75F40125C00075
The Univeristy Of Texas M.D. Anderson Cancer Center · Department Of Health And Human Services · September 16, 2025
The Univeristy Of Texas M.D. Anderson Cancer Center was awarded a federal contract by Department Of Health And Human Services (Food And Drug Administration) on September 16, 2025 for $1.18 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Beltsville, MD. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 30, 2025.
Contract details
- PIID
- 75F40125C00075
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Competed Under Sap
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- General Science And Technology R&D Services; General Science And Technology; Basic Research
- Place of performance
- Beltsville, MD
- First action
- September 16, 2025
- Latest action
- September 30, 2025
Description
BAA-MD ANDERSON-STATISTICAL DESIGNS AND CONSIDERATIONS FOR DOSE OPTIMIZATION FY25C1FP6
Modification timeline
-
September 30, 2025Mod P00001 · Funding Only Action$1.18M
-
September 16, 2025Base award$1.06M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75F40125C00075?
Contract 75F40125C00075 is a federal contract awarded to The Univeristy Of Texas M.D. Anderson Cancer Center by Department Of Health And Human Services on September 16, 2025 for $1.18 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 1 time since the base award.
Who won contract 75F40125C00075?
The Univeristy Of Texas M.D. Anderson Cancer Center won contract 75F40125C00075 from Department Of Health And Human Services.
How much is contract 75F40125C00075 worth?
Contract 75F40125C00075 has obligated $1.18 million to date.